1. Home
  2. BDSX vs TPCS Comparison

BDSX vs TPCS Comparison

Compare BDSX & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • TPCS
  • Stock Information
  • Founded
  • BDSX 2005
  • TPCS 1956
  • Country
  • BDSX United States
  • TPCS United States
  • Employees
  • BDSX N/A
  • TPCS N/A
  • Industry
  • BDSX Precision Instruments
  • TPCS Metal Fabrications
  • Sector
  • BDSX Health Care
  • TPCS Industrials
  • Exchange
  • BDSX Nasdaq
  • TPCS Nasdaq
  • Market Cap
  • BDSX 53.0M
  • TPCS 51.4M
  • IPO Year
  • BDSX 2020
  • TPCS N/A
  • Fundamental
  • Price
  • BDSX $6.57
  • TPCS $5.02
  • Analyst Decision
  • BDSX Strong Buy
  • TPCS
  • Analyst Count
  • BDSX 5
  • TPCS 0
  • Target Price
  • BDSX $32.50
  • TPCS N/A
  • AVG Volume (30 Days)
  • BDSX 276.0K
  • TPCS 31.0K
  • Earning Date
  • BDSX 11-03-2025
  • TPCS 08-21-2025
  • Dividend Yield
  • BDSX N/A
  • TPCS N/A
  • EPS Growth
  • BDSX N/A
  • TPCS N/A
  • EPS
  • BDSX N/A
  • TPCS N/A
  • Revenue
  • BDSX $76,556,000.00
  • TPCS $33,424,000.00
  • Revenue This Year
  • BDSX $18.78
  • TPCS N/A
  • Revenue Next Year
  • BDSX $26.42
  • TPCS N/A
  • P/E Ratio
  • BDSX N/A
  • TPCS N/A
  • Revenue Growth
  • BDSX 25.70
  • TPCS 3.78
  • 52 Week Low
  • BDSX $3.44
  • TPCS $2.05
  • 52 Week High
  • BDSX $34.39
  • TPCS $6.25
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 52.63
  • TPCS 43.59
  • Support Level
  • BDSX $5.84
  • TPCS $4.60
  • Resistance Level
  • BDSX $6.94
  • TPCS $5.41
  • Average True Range (ATR)
  • BDSX 0.61
  • TPCS 0.32
  • MACD
  • BDSX -0.27
  • TPCS -0.04
  • Stochastic Oscillator
  • BDSX 34.52
  • TPCS 23.06

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.

Share on Social Networks: